⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

PHAT

Phathom Pharmaceuticals, Inc.

Healthcare · Biotechnology

6.22USD

-0.0600 (-0.96%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Computing valuation metrics…

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on PHAT.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Valuation

P/E (TTM)

—

P/E (Forward)

5.78x

EV/EBITDA

—

EV/Revenue

3.18x

P/S (TTM)

1.83x

P/B

—

FCF Yield

-4.18%

Dividend Yield

0.00%

Gross Margin

80.68%

Operating Margin

-9.26%

Net Margin

-30.19%

Peer Comparison — Biotechnology

CompanyMkt CapP/EEV/EBITDAFCF YieldRev GrowthDiv Yield
PHATPhathom Pharmaceuticals, Inc.$503.20M——-4.18%71.14%0.00%
VRTXVertex Pharmaceuticals Incorporated$136.78B31.45x25.69x1.92%12.50%0.00%

Subject metrics from SEC filings where available; peer metrics from cached market data.

MRNAModerna, Inc.
$88.93B
—
—
0.34%
2.10%
0.00%
REGNRegeneron Pharmaceuticals, Inc.$83.73B20.11x16.16x3.66%16.70%0.46%
ARGXargenx SE$56.46B31.10x735.70x—52.10%0.00%
RPRXRoyalty Pharma plc$37.46B34.48x25.65x-3.19%16.50%1.45%
ROIVRoivant Sciences Ltd.$27.10B——-4.12%-33.50%0.00%
INCYIncyte Corporation$23.69B14.89x9.88x4.98%37.70%0.00%
BNTXBioNTech SE$22.39B——-1.11%-59.50%0.00%